Performance analysis of Oaktree Acquisition Corp III Life Sciences - Warrants(04/10/2029) (OACCW)
Annual Return
Since Dec 16, 2024, OACCW has had an average annual return of +36.79%, outperforming the benchmark SPY, which returned +18.05% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +11.27% | -19.21% | +75.76% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +12.68% | -6.25% | +0% | +16.99% | -20.22% | +12.86% | +11.27% | ||||||
| 2025 | -21.62% | -1.28% | +10.29% | -13.33% | +27.69% | +5.42% | -2.86% | -5.88% | -6.25% | +32% | -23.23% | -6.58% | -19.21% |
| 2024 | +75.76% | +75.76% |
Drawdown analysis of Oaktree Acquisition Corp III Life Sciences - Warrants(04/10/2029) (OACCW)
The maximum drawdown for the OACCW was -49.56%, occurring on Apr 7, 2025. This drawdown has not yet recovered.
The current OACCW drawdown is -30.09%.
Since Dec 16, 2024 OACCW has experienced the following drawdowns:
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -49.56% | Jan 3, 2025 | 63 | Apr 7, 2025 | Ongoing | Ongoing | Ongoing |
| -12.86% | Dec 27, 2024 | 1 | Dec 30, 2024 | 1 | Dec 31, 2024 | 2 |